COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.76
+4.62%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- $110.0K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.28
- EPS estimate
- -$0.35
- Revenue actual
- $221.9K
- Revenue estimate
- $130.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -147.0%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $13
- PT range
- $12 – $14
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026